BioCentury
ARTICLE | Clinical News

QLT Phototherapeutics Inc. regulatory update

September 8, 1998 7:00 AM UTC

The FDA's Oncologic Drugs Advisory Committee recommended that QLTIF's photodynamic therapy (PDT) using Photofrin porfimer sodium be approved for reduction of obstruction and palliation of symptoms in...